312 related articles for article (PubMed ID: 2808206)
1. In-vitro susceptibility of Haemophilus influenzae to meropenem compared with imipenem, five other beta-lactams, chloramphenicol and ciprofloxacin.
Powell M; Seetulsingh P; Williams JD
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():175-81. PubMed ID: 2808206
[TBL] [Abstract][Full Text] [Related]
2. Reevaluation of interpretive criteria for Haemophilus influenzae by using meropenem (10-microgram), imipenem (10-microgram), and ampicillin (2- and 10-microgram) disks.
Zerva L; Biedenbach DJ; Jones RN
J Clin Microbiol; 1996 Aug; 34(8):1970-4. PubMed ID: 8818892
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum beta-lactamases.
Moczygemba LR; Frei CR; Burgess DS
Clin Ther; 2004 Nov; 26(11):1800-7. PubMed ID: 15639692
[TBL] [Abstract][Full Text] [Related]
4. In-vitro activity of imipenem against 100 strains of serotype b and nontypable Haemophilus influenzae, including strains resistant to ampicillin, chloramphenicol or both.
Campos JM; Gill CJ; Ahonkhai VI
J Antimicrob Chemother; 1985 Nov; 16(5):549-54. PubMed ID: 3878361
[TBL] [Abstract][Full Text] [Related]
5. In vitro activities of aztreonam, imipenem, and amoxycillin-clavulanate against ampicillin-resistant Haemophilus influenzae.
Powell M; Williams JD
Antimicrob Agents Chemother; 1987 Dec; 31(12):1871-3. PubMed ID: 3501940
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activity of imipenem against Haemophilus influenzae and Haemophilus parainfluenzae.
Cerami AT; Shungu DL
Antimicrob Agents Chemother; 1986 Jul; 30(1):179-80. PubMed ID: 3489437
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo activities of meropenem and comparable antimicrobial agents against Haemophilus influenzae, including beta-lactamase-negative ampicillin-resistant strains.
Miyazaki S; Fujikawa T; Kanazawa K; Yamaguchi K
J Antimicrob Chemother; 2001 Nov; 48(5):723-6. PubMed ID: 11679563
[TBL] [Abstract][Full Text] [Related]
8. Selection and transformation of non-beta-lactamase-mediated insusceptibility to beta-lactams in Haemophilus influenzae: lack of cross-resistance between carbapenems and other agents.
Powell M; Livermore DM
J Antimicrob Chemother; 1990 Dec; 26(6):741-7. PubMed ID: 2081716
[TBL] [Abstract][Full Text] [Related]
9. Activities of newer beta-lactam antibiotics against ampicillin, chloramphenicol, or multiply-resistant Haemophilus influenzae.
Strandberg DA; Jorgensen JH; Drutz DJ
Diagn Microbiol Infect Dis; 1984 Sep; 2(4):333-7. PubMed ID: 6333316
[TBL] [Abstract][Full Text] [Related]
10. Activity of a new carbapenem antibiotic, meropenem, against Haemophilus influenzae strains with beta-lactamase- and non-enzyme-mediated resistance to ampicillin.
Jorgensen JH; Maher LA; Howell AW
Antimicrob Agents Chemother; 1991 Mar; 35(3):600-2. PubMed ID: 2039214
[TBL] [Abstract][Full Text] [Related]
11. In-vitro activity of meropenem against Neisseria gonorrhoeae, Haemophilus influenzae and H. ducreyi from Canada and Kenya.
Slaney L; Chubb H; Mohammed Z; Ronald A
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():183-6. PubMed ID: 2509415
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activities of piperacillin-tazobactam against Haemophilus influenzae isolates, including beta-lactamase-negative ampicillin-resistant and beta-lactamase-positive amoxicillin-clavulanate-resistant isolates, and mutations in their quinolone resistance-determining regions.
Hirakata Y; Ohmori K; Mikuriya M; Saika T; Matsuzaki K; Hasegawa M; Hatta M; Yamamoto N; Kunishima H; Yano H; Kitagawa M; Arai K; Kawakami K; Kobayashi I; Jones RN; Kohno S; Yamaguchi K; Kaku M
Antimicrob Agents Chemother; 2009 Oct; 53(10):4225-30. PubMed ID: 19651910
[TBL] [Abstract][Full Text] [Related]
13. Effect of the inoculum size on carbapenem susceptibilities of beta-lactamase-negative, ampicillin-resistant Haemophilus influenzae.
Miyazaki H; Horii T; Nagura O; Suda T; Chida K; Nakamura H
Curr Microbiol; 2009 Jan; 58(1):18-24. PubMed ID: 18815831
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
[TBL] [Abstract][Full Text] [Related]
15. Potent activity of meropenem against Escherichia coli arising from its simultaneous binding to penicillin-binding proteins 2 and 3.
Sumita Y; Fukasawa M
J Antimicrob Chemother; 1995 Jul; 36(1):53-64. PubMed ID: 8537284
[TBL] [Abstract][Full Text] [Related]
16. Isolates of β-lactamase-negative ampicillin-resistant Haemophilus influenzae causing invasive infections in Spain remain susceptible to cefotaxime and imipenem.
García-Cobos S; Arroyo M; Pérez-Vázquez M; Aracil B; Lara N; Oteo J; Cercenado E; Campos J
J Antimicrob Chemother; 2014 Jan; 69(1):111-6. PubMed ID: 23943391
[TBL] [Abstract][Full Text] [Related]
17. In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms.
Chen HY; Livermore DM
J Antimicrob Chemother; 1994 May; 33(5):949-58. PubMed ID: 8089068
[TBL] [Abstract][Full Text] [Related]
18. [Surveillance of antimicrobial susceptibility of Haemophilus influenzae isolates from children in Beijing, Shanghai, and Guangzhou 2000 - 2002].
Shen XZ; Lu Q; Deng L; Yu SJ; Zhang H; Deng QL; Jiang M; Hu YY; Yang YH
Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1335-9. PubMed ID: 15387940
[TBL] [Abstract][Full Text] [Related]
19. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
Zhao C; Xie W; Zhang W; Ye Z; Wu H
Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
[TBL] [Abstract][Full Text] [Related]
20. [Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study].
Korten V; Söyletir G; Yalçın AN; Oğünç D; Dokuzoğuz B; Esener H; Ulusoy S; Tünger A; Aygen B; Sümerkan B; Arman D; Dizbay M; Akova M; Hasçelik G; Eraksoy H; Başaran S; Köksal I; Bayramoğlu G; Akalın H; Sınırtaş M
Mikrobiyol Bul; 2011 Apr; 45(2):197-209. PubMed ID: 21644063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]